mTOR-dependent signalling in Alzheimer's disease

•  Introduction •  Neurodegeneration and neurofibrillary degeneration in Alzheimer's disease brains •  Dysfunction of protein synthesis mediated by mTOR‐dependent signalling in Alzheimer's disease brains •  Neurodegeneration mediated by mTOR‐dependent signalling •  Tau phosphorylation mediated by mTOR‐dependent signalling •  mTOR‐dependent signalling in lymphocytes of AD: potential biomarkers for AD diagnosis •  mTOR‐dependent signalling and other neurodegenerative diseases •  Perspectives •  Conclusions

• Publication year

  2008

• Venue

  Journal of Cellular and Molecular Medicine

• Publication date

  2008-10-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1582-4934.2008.00509.xPMID 19210753PMCID 3828871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coupling of Mammalian Target of Rapamycin with Phosphoinositide 3-Kinase Signaling Pathway Regulates Protein Phosphatase 2A- and Glycogen Synthase Kinase-3β-dependent Phosphorylation of Tau*

  2008cited by this paper
• MAPK and mTOR pathways are involved in cadmium‐induced neuronal apoptosis

  2008cited by this paper
• Differential Incorporation of Tau Isoforms in Alzheimer's Disease

  2008cited by this paper
• Increased mTORC1 signaling UPRegulates stress.

  2008cited by this paper
• Role of mTOR in physiology and pathology of the nervous system.

  2008cited by this paper
• Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.

  2008cited by this paper
• Parallel increase in p70 kinase activation and tau phosphorylation (S262) with Aβ overproduction

  2008cited by this paper
• p70 S6 Kinase and Tau in Alzheimer's Disease

  2008cited by this paper
• Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology

  2007cited by this paper
• Phosphorylation of human microtubule‐associated protein tau by protein kinases of the AGC subfamily

  2007cited by this paper
• Tau and neurofilament proteins in Alzheimer's disease and related cell models

  2007cited by this paper
• The two TORCs and Akt.

  2007cited by this paper
• Increased autophagy in transgenic mice with a G93A mutant SOD1 gene.

  2007cited by this paper
• Peripheral p70S6k levels and emotional memory in patients with Alzheimer's disease.

  2006cited by this paper
• The immunosuppressant rapamycin exacerbates neurotoxicity of Aβ peptide

  2006influential reference
• The growing role of mTOR in neuronal development and plasticity

  2006cited by this paper
• Activated mTOR and PKR Kinases in Lymphocytes Correlate with Memory and Cognitive Decline in Alzheimer’s Disease

  2006cited by this paper
• Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.

  2006cited by this paper
• RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation

  2006cited by this paper
• Global Translational Responses to Oxidative Stress Impact upon Multiple Levels of Protein Synthesis*

  2006cited by this paper
• TOR signaling in growth and metabolism.

  2006cited by this paper
• TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model.

  2006cited by this paper
• P70 S6 kinase mediates tau phosphorylation and synthesis

  2006cited by this paper
• Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease.

  2006cited by this paper
• Genetic complexity of Alzheimer's disease: Successes and challenges

  2006cited by this paper
• The relation between p70S6k expression in lymphocytes and the decline of cognitive test scores in patients with Alzheimer disease.

  2005cited by this paper
• Global Gene Expression Profiling Reveals Widespread yet Distinctive Translational Responses to Different Eukaryotic Translation Initiation Factor 2B-Targeting Stress Pathways

  2005cited by this paper
• Molecular Organization of Target of Rapamycin Complex 2*

  2005cited by this paper
• Mechanism of zinc‐induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3β in SH‐SY5Y neuroblastoma cells

  2005cited by this paper
• Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron*

  2005cited by this paper
• Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms

  2005cited by this paper
• Levels of mTOR and its downstream targets 4E‐BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain

  2005cited by this paper
• Analysis of mTOR signaling by the small G‐proteins, Rheb and RhebL1

  2005cited by this paper
• mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's disease

  2005influential reference
• Ribosome Dysfunction Is an Early Event in Alzheimer's Disease

  2005cited by this paper
• Role of P70 S6 kinase in the formation of tau pathologies in Alzheimer´s disease

  2005cited by this paper
• Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

  2004cited by this paper
• Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?

  2004cited by this paper
• Insulin Promotes Rat Retinal Neuronal Cell Survival in a p70S6K-dependent Manner*

  2004cited by this paper
• Transient Cerebral Ischemia Induces Aberrant Neuronal Cell Cycle Re-entry and Alzheimer's Disease-like Tauopathy in Female Rats*

  2004cited by this paper
• Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease

  2004cited by this paper
• Expression of tau mRNA and soluble tau isoforms in affected and non‐affected brain areas in Alzheimer's disease

  2004cited by this paper
• An RNA‐dependent protein kinase is involved in tunicamycin‐induced apoptosis and Alzheimer's disease

  2004cited by this paper
• Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain

  2004cited by this paper
• Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease.

  2003cited by this paper
• TOR signalling in bugs, brain and brawn

  2003cited by this paper
• Upstream Signaling Pathways Leading to the Activation of Double-stranded RNA-dependent Serine/Threonine Protein Kinase in β-Amyloid Peptide Neurotoxicity*

  2003cited by this paper
• Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice.

  2003cited by this paper
• Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.

  2003influential reference
• Homodirectional changes in transcriptome composition and mRNA translation induced by rapamycin and heat shock

  2003cited by this paper
• mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo

  2003cited by this paper
• mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

  2002cited by this paper
• Involvement of double‐stranded RNA‐dependent protein kinase and phosphorylation of eukaryotic initiation factor‐2α in neuronal degeneration

  2002cited by this paper
• Regulation of elongation factor-2 kinase by pH.

  2002cited by this paper
• Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

  2002cited by this paper
• BAD and Bcl-2 regulation are early events linking neuronal endoplasmic reticulum stress to mitochondria-mediated apoptosis.

  2002cited by this paper
• Phosphorylation of eukaryotic initiation factor-2&agr; (eIF2&agr;) is associated with neuronal degeneration in Alzheimer's disease

  2002cited by this paper
• Overexpression of four‐repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease

  1999cited by this paper
• Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis.

  1998cited by this paper
• FK506 antagonizes apoptosis and c‐jun protein expression in neuronal cultures

  1998cited by this paper
• Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation.

  1997cited by this paper
• The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain.

  1995cited by this paper
• Regulation of serine protease activity by aluminum: implications for Alzheimer disease.

  1993cited by this paper
• In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer's disease.

  1992cited by this paper
• Enzyme Activities in Relation to pH and Lactate in Postmortem Brain in Alzheimer‐Type and Other Dementias

  1990cited by this paper
• Translational control of gene expression in the human brain.

  1989cited by this paper
• A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

  1989cited by this paper
• Alzheimer's disease-associated reduction of polysomal mRNA translation.

  1989cited by this paper
• Lactate and pH in the Brain: Association and Dissociation in Different Pathophysiological States

  1987cited by this paper
• Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex.

  1984cited by this paper

• Shared early molecular mechanisms revealed in P301S and 5xFAD Alzheimer’s disease mouse models

  2025cites this paper
• Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets.

  2025cites this paper
• Neuroprotective Effects of Phosphodiesterase Inhibitors on Sestrin-2 (SESN2) Expression and Autophagy in Alzheimer’s Disease Model

  2025cites this paper
• Monoterpene-rich essential oil from Artemisia santonicum L. exerts neuroprotective effects in Aβ-induced SH-SY5Y cells: Modulation of tau pathology, neuroinflammation, oxidative stress, and synaptic-metabolic pathways

  2025cites this paper
• Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration

  2025cites this paper
• Nutrient Sensing Receptor GPRC6A Regulates mTORC1 Signaling and Tau Biology

  2024cites this paper
• Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies

  2024cites this paper
• Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer's disease

  2024cites this paper
• Brain insulin resistance in Down syndrome: Involvement of PI3K-Akt/mTOR axis in early-onset of Alzheimer's disease and its potential as a therapeutic target.

  2024cites this paper
• Exploring complexities of Alzheimer's disease: New insights into molecular and cellular mechanisms of neurodegeneration and targeted therapeutic interventions.

  2024cites this paper
• Connexin43 Contributes to Alzheimer’s Disease by Promoting the Mitochondria-Associated Membrane-Related Autophagy Inhibition

  2024cites this paper
• HIF-1α downregulates the APP protein after oxygen and glucose deprivation in the APPswe/PSEN1 mouse model of Alzheimer’s disease

  2024cites this paper
• Hearing modulation affects Alzheimer’s disease progression linked to brain inflammation: a study in mouse models

  2024cites this paper
• Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs

  2024cites this paper
• Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration

  2023cites this paper
• Causal Association Between mTOR-Dependent Protein Levels and Alzheimer’s Disease: A Mendelian Randomization Study

  2023cites this paper
• Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis

  2023cites this paper
• A common molecular and cellular pathway in developing Alzheimer and cancer

  2023cites this paper
• Terahertz Irradiation Improves Cognitive Impairments and Attenuates Alzheimer’s Neuropathology in the APPSWE/PS1DE9 Mouse: A Novel Therapeutic Intervention for Alzheimer’s Disease

  2023cites this paper
• Aberrant DJ-1 expression underlies L-type calcium channel hypoactivity in dendrites in tuberous sclerosis complex and Alzheimer’s disease

  2023cites this paper
• A strategic tool to improve the study of molecular determinants of Alzheimer's disease: The role of glyceraldehyde.

  2023cites this paper
• Rapamycin Responds to Alzheimer’s Disease: A Potential Translational Therapy

  2023cites this paper
• Association of mTOR Pathway and Conformational Alterations in C-Reactive Protein in Neurodegenerative Diseases and Infections

  2023cites this paper
• EGFR is a potential dual molecular target for cancer and Alzheimer’s disease

  2023cites this paper
• RPS6 transcriptional modulation in neural tissues of Nauphoeta cinerea during streptozotocin-associated sugar metabolism impairment.

  2022cites this paper
• The Therapeutic Relevance of Urolithins, Intestinal Metabolites of Ellagitannin-Rich Food: A Systematic Review of In Vivo Studies

  2022cites this paper
• Gamma Frequency Inhibits the Secretion and Aggregation of Amyloid-β and Decreases the Phosphorylation of mTOR and Tau Proteins in vitro

  2022cites this paper
• Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways

  2022cites this paper
• Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential

  2022cites this paper
• Oxidative stress and mTOR in Down syndrome brain: Link to Alzheimer's dysmetabolism, neuropathology, and possible therapies

  2022cites this paper
• Zinc in Cognitive Impairment and Aging

  2022cites this paper
• Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease

  2022cites this paper
• The Interaction of mTOR and Nrf2 in Neurogenesis and Its Implication in Neurodegenerative Diseases

  2022cites this paper
• Insulin-like growth factor 5 associates with human Aß plaques and promotes cognitive impairment

  2022cites this paper
• mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis.

  2022cites this paper
• Inhibiting Autophagy Pathway of PI3K/AKT/mTOR Promotes Apoptosis in SK-N-SH Cell Model of Alzheimer's Disease

  2022cites this paper
• Cooperation of cell adhesion and autophagy in the brain: Functional roles in development and neurodegenerative disease

  2021cites this paper
• Rapamycin attenuated zinc-induced tau phosphorylation and oxidative stress in animal model: Involvement of dual mTOR/p70S6K and Nrf2/HO-1 pathways

  2021cites this paper
• Crosstalk between epigenetics and mTOR as a gateway to new insights in pathophysiology and treatment of Alzheimer's disease.

  2021cites this paper
• mTOR in Alzheimer Disease and Its Earlier Stages: Links to Oxidative Damage in the Progression of this Dementing Disorder.

  2021cites this paper
• The molecular view of mechanical stress of brain cells, local translation, and neurodegenerative diseases

  2021cites this paper
• Obscure Involvement of MYC in Neurodegenerative Diseases and Neuronal Repair

  2021cites this paper
• Andrographolide, a Diterpene from Andrographis paniculata, and its Influence on the Progression of Neurodegenerative Disorders

  2021cites this paper
• Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

  2021cites this paper
• Where Dopaminergic and Cholinergic Systems Interact: A Gateway for Tuning Neurodegenerative Disorders

  2021cites this paper
• Rapamycin Ameliorates Cognitive Impairments and Alzheimer’s Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice

  2020cites this paper
• Neuronal insulin signaling and brain structure in nondemented older adults: the Atherosclerosis Risk in Communities Study.

  2020cites this paper
• Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential

  2020cites this paper
• Signalling Pathways Implicated in Alzheimer′s Disease Neurodegeneration in Individuals with and without Down Syndrome

  2020cites this paper
• Neuronal insulin signaling and brain structure in non-demented older adults: The ARIC Study

  2020cites this paper
• Insulin resistance, diabetes, and metabolic syndrome

  2020cites this paper
• Treating Alzheimer’s disease pathology: Present to alternative modalities

  2020cites this paper
• Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer’s Disease

  2020cites this paper
• IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model

  2020cites this paper
• APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease.

  2020cites this paper
• A meta-analysis of the effect of binge drinking on the oral microbiome and its relation to Alzheimer’s disease

  2020cites this paper
• A transition to degeneration triggered by oxidative stress in degenerative disorders

  2020cites this paper
• Molecular mechanisms of cellular dysfunction caused by a tauopathy-associated fragment

  2019cites this paper
• Upregulated levels and pathological aggregation of abnormally phosphorylated Tau-protein in children with neurodevelopmental disorders.

  2019cites this paper
• Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together

  2019influential citation
• Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice

  2019cites this paper
• mTOR signalling: jack-of-all-trades 1.

  2019cites this paper
• Stress and the Etiopathogenesis of Alzheimer's Disease and Depression.

  2019cites this paper
• Alcohol Drinking Exacerbates Neural and Behavioral Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease

  2019cites this paper
• FTO: An Emerging Molecular Player in Neuropsychiatric Diseases.

  2019cites this paper
• Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities

  2019cites this paper
• Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives

  2019cites this paper
• Prophylactic effect of physical exercise on Aβ1-40-induced depressive-like behavior: Role of BDNF, mTOR signaling, cell proliferation and survival in the hippocampus.

  2019cites this paper
• Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes.

  2019cites this paper
• mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease‐like dementia

  2018cites this paper
• Influence of mTOR signaling pathway on ketamine-induced injuries in the hippocampal neurons of rats

  2018cites this paper
• Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats

  2018cites this paper
• mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases

  2018cites this paper
• Compound C enhances tau phosphorylation at Serine396 via PI3K activation in an AMPK and rapamycin independent way in differentiated SH-SY5Y cells.

  2018cites this paper
• Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β

  2018cites this paper
• Promising horizon to alleviate Alzeheimer's disease pathological hallmarks via inhibiting mTOR signaling pathway: A new application for a commonplace analgesic.

  2018cites this paper
• Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain

  2018cites this paper
• The Role of mTOR and Ubiquitin in Plaque and Tangle Formation in Alzheimer's Disease Pathogenesis: A Report of Co‐localization in Two Alzheimer's Autopsy Cases

  2018cites this paper
• Both decreased Akt expression and mTOR phosphorylation are related to decreased neuronal differentiation in the hippocampal alveus of aged mice

  2018cites this paper
• Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.

  2018cites this paper
• Blood-Based Kinase Assessments in Alzheimer’s Disease

  2018cites this paper
• The role of PI 3 K / AKT pathway and its therapeutic possibility in Alzheimer ’ s disease

  2017cites this paper
• Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's disease.

  2017cites this paper
• Widespread Genotype-Phenotype Correlations in Intellectual Disability

  2017cites this paper
• Type II Diabetes and Metabolic Syndrome as Risk Factors for Alzheimer’s Disease

  2017cites this paper
• Perspective, Summary, and Directions for Future Research on Alzheimer’s Disease

  2017cites this paper
• Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases.

  2017cites this paper
• Molecular mechanisms of autism as a form of synaptic dysfunction

  2017cites this paper
• Treatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to aging

  2017cites this paper
• Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies

  2017cites this paper
• Role of mammalian target of rapamycin signaling in autophagy and the neurodegenerative process using a senescence accelerated mouse-prone 8 model

  2017cites this paper
• Beneficial effects of rapamycin in a Drosophila model for hereditary spastic paraplegia

  2017cites this paper
• Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase.

  2017cites this paper
• mTOR referees memory and disease through mRNA repression and competition

  2017cites this paper
• The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics

  2017influential citation
• Screening the Molecular Framework Underlying Local Dendritic mRNA Translation

  2017cites this paper
• Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice.

  2017cites this paper
• Sixty years old is the breakpoint of human frontal cortex aging

  2017cites this paper
• Neurochemical Aspects of β-Amyloid Cascade Hypothesis for Alzheimer’s Disease: A Critical Evaluation

  2017cites this paper
• Lithium: Neurotransmission and Cellular Mechanism Pathways Underlying Neuroprogression in Bipolar Disorder

  2017cites this paper